絞り込み

17897

広告

8420件中 21件~40件表示    検索結果をPubMedで見る PubMedで見る

Renoprotective effects of paramylon, a β-1,3-D-Glucan isolated from Euglena gracilis Z in a rodent model of chronic kidney disease.

Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes.

Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes.

Integration of GWAS Summary Statistics and Gene Expression Reveals Target Cell Types Underlying Kidney Function Traits.

Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.

Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.

Alk1 haploinsufficiency causes glomerular dysfunction and microalbuminuria in diabetic mice.

Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases.

Tmem63c is a potential pro-survival factor in angiotensin II-treated human podocytes.

An information theoretic approach to insulin sensing by human kidney podocytes.

Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease.

PolyMet-HA nanocomplexs regulates glucose uptake by inhibiting SHIP2 activity.

Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport Syndrome.

Podocyte and endothelial-specific elimination of BAMBI identifies differential transforming growth factor-β pathways contributing to diabetic glomerulopathy.

Podocyte stress and detachment measured in urine are related to mean arterial pressure in healthy humans.

Sulforaphane suppresses obesity-related glomerulopathy-induced damage by enhancing autophagy via Nrf2.

LIM-Nebulette Reinforces Podocyte Structural Integrity by Linking Actin and Vimentin Filaments.

Megalin-mediated albumin endocytosis in cultured murine mesangial cells.

[COVID-19: The Perspective Of Nephrology].

Role of advanced glycation end products and insulin resistance in diabetic nephropathy.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります